Pharma VC Funds

Chicago Ventures is a venture capital firm based in Chicago, focusing on seed-stage investments in technology companies. The firm leads early rounds, often stepping in when other investors might overlook startups. Chicago Ventures has invested in over 100 companies, raising significant follow-on capital since its inception in 2012. Prominent companies in their portfolio include Cameo, SpotHero, project44, and G2. Cameo is known for its personalized celebrity video messages, SpotHero for its parking reservation service, project44 for its logistics technology, and G2 for being the largest software marketplace globally. Other notable investments include HealthJoy, a healthcare guidance platform, and Kin, which simplifies homeowners insurance. Chicago Ventures recently closed its third fund, raising $63 million to continue backing startups that might be initially passed over by other investors. They typically invest between $1.5 million to $2 million per startup and aim to make 25 new investments with this fund. The firm's investment strategy emphasizes a hands-on approach, taking board seats and actively supporting the companies in their portfolio. This approach helps startups navigate their early growth stages and scale effectively.

Chingona Ventures, founded in 2019 by Samara Hernandez and based in Chicago, focuses on early-stage investments, particularly in startups led by women and minorities. The firm emphasizes sectors such as fintech, food technology, health tech, wellness, and the future of work and learning. Chingona Ventures has made significant investments in companies like Career Karma, EarlyBird, and Suma Wealth. The firm recently closed a $52 million Fund II, with contributions from prominent partners including PayPal Ventures and Melinda Gates’ Pivotal Ventures. This fund allows them to increase their typical investment size to between $250,000 and $1 million. The firm is known for backing founders who are often overlooked and operates primarily in the Midwest. Their mission is to support innovative solutions and diverse leadership in the tech industry. The leadership team, including Senior Advisor Sonia Nagar and Associate Grisel Hernandez, brings extensive experience in venture capital and strategic guidance.

CincyTech is a venture capital firm based in Cincinnati, Ohio, focusing on seed-stage investments to drive economic growth and innovation in the Midwest. Founded in 2006, CincyTech has invested in over 140 companies, particularly in the healthcare, technology, and life sciences sectors. Some of their notable investments include Enable Injections, which raised $215 million in Series C funding for their wearable drug delivery devices, and Genetesis, a company that secured $17.5 million to advance their Cardioflux diagnostic imaging platform. Other prominent portfolio companies include ReadySet Surgical, Standard Bariatrics, and NaviStone, which leverage innovative solutions in their respective fields. In 2022, CincyTech reported a record $391 million in co-investments in its portfolio companies, reflecting its significant impact on the regional economy. The firm continues to focus on partnering with visionary founders to transform ideas into world-class companies, supporting them with strategic guidance and access to a robust network of co-investors.

CircleUp Growth Partners, based in San Francisco, is a venture capital firm specializing in early-stage consumer brands. Their data-driven approach is powered by Helio, an advanced platform that provides comprehensive consumer market insights, enhancing the decision-making process for investments and supporting post-funding growth​. CircleUp has backed notable brands such as Halo Top Creamery, Back to the Roots, and Rhythm Superfoods, focusing on sectors like food and beverage, personal care, beauty, pet products, and household consumables​. CircleUp's investment strategy targets companies with revenues between $1 million and $20 million, typically providing growth equity ranging from $1 million to $10 million. They emphasize supporting visionary entrepreneurs who are passionate about their products and have a clear vision for their brands​. The firm is led by a team of experienced partners, including Sam Blumenthal and Karen Howland, who bring extensive backgrounds in consumer investing and operational support​ (CircleUp)​. CircleUp's holistic approach involves not just funding but also leveraging partnerships and community networks to foster collaboration and accelerate growth.

City Light Capital is an early-stage venture capital firm based in New York, focusing on investments that generate measurable social impact in the areas of education, safety and care, and the environment. They believe in leveraging private markets to address complex, intertwined social issues through scalable solutions. City Light invests in companies where financial success is directly tied to social impact, ensuring that growth in revenue equates to better lives at scale. The firm's portfolio includes a diverse array of impactful companies, such as Maven Clinic, Headspace Health, and OhmConnect, which provide solutions ranging from healthcare to clean energy. City Light typically invests between $50,000 and $3 million, often leading or co-leading rounds at the seed stage and beyond. They also have a dedicated seed investment program, City Spark, which nurtures early-stage companies with the potential for significant social impact. City Light's team is composed of experienced investors, including Partners Josh Cohen, Tom Groos, and Jeff Rinehart. They emphasize close collaboration with entrepreneurs to maximize both financial returns and social outcomes. The firm operates primarily in the United States, with a strong presence in major investment hubs like New York and the Midwest.

Civilization Ventures is a venture capital firm founded in 2017 with a strong focus on health tech and biology innovations. Based in Silicon Valley, the firm has grown from a $1M pilot seed fund to managing over $100M in capital. They have invested in over 60 companies across genomics, diagnostics, digital health, and synthetic biology, emphasizing preventative, personalized, and regenerative healthcare solutions. Notable investments include Rocket Pharma, which focuses on gene therapies for rare diseases, and Singular Bio, acquired by Invitae to enhance genetic screening in early pregnancy. Other significant exits include Lemonaid Health, acquired by 23andMe, and Rewrite, a gene editing company acquired by Intellia. The team at Civilization Ventures is composed of experienced biopharma executives and operators who have founded and sold companies. They support founders through a vast network and their extensive experience in the field. Additionally, they offer a unique fellowship program to train PhDs to become future entrepreneurs in the life sciences sector.

Claris Ventures is an Italian venture capital firm established in 2019, focusing on early-stage investments in high-potential biopharma companies. The firm's first fund, Claris Biotech I, targets innovations that are poised to enter clinical trials within 12 to 24 months. Claris Ventures is particularly interested in therapeutic areas such as oncology, immunology, and rare diseases—sectors that often have significant unmet medical needs. The firm's strategy involves not only providing capital but also offering hands-on support in areas like project management, finance, and strategic development, allowing scientific founders to focus on their research and development. Claris Ventures aims to build value around strong scientific evidence, with a mission to make a substantial impact on patient care. Claris Ventures leverages Italy's robust R&D ecosystem, drawing from local research centers, clinical institutions, and international collaborations. The team, led by Managing Partners Pietro Puglisi and Ciro Spedaliere, includes experienced professionals who are committed to guiding portfolio companies through the critical early stages of development. Some notable companies in their portfolio include NeoPhore, Resalis Therapeutics, and Kither Biotech, which are all working on breakthrough therapies in their respective fields.

Clave Capital is a prominent venture capital firm based in Pamplona, Spain, with a strong focus on the healthcare sector. Notable for their recent €50 million Clave Innohealth fund, they target high-growth potential startups across Europe, specifically in medtech, digital health, health-nutrition, and biotech sectors. Clave Capital’s portfolio includes promising startups like Innitius, which focuses on improving diagnostics for women’s health. Clave Capital primarily invests in early-stage to Series A funding rounds, with initial contributions ranging from €500k to €1 million, and potential follow-on investments up to €3 million per project. Their geographic focus extends throughout Spain and Europe. The firm’s investment strategy emphasizes not only financial backing but also active involvement in the growth and development of their portfolio companies. They maintain close relationships with research centers and hospitals, providing valuable expertise and connections to foster innovation. Clave Capital's experienced team, led by Chairman and CEO José Javier Armendariz and Director of Funds Santiago Lozano, has a track record of over 20 years and 90 investments, which positions them as a significant player in the European healthcare investment landscape. For startups looking to engage with Clave Capital, it’s advisable to highlight innovative potential and market leadership capabilities in the healthcare domain. Their preference for hands-on involvement means that demonstrating a collaborative approach could be beneficial.

Clay Capital, formerly known as VisVires New Protein, is a Singapore-based venture capital firm focused on agrifood technology. In 2023, the firm closed its second fund at $145 million, signaling a strong commitment to transforming the food and agriculture sectors. Clay Capital backs innovative startups across Europe, Asia, and Israel that are working to create sustainable and regenerative food systems. Its investment strategy targets technologies that address key issues like food security, sustainability, and environmental health. With initial investments ranging from $3 million to $8 million, Clay Capital supports startups working on solutions in areas such as regenerative agriculture, crop disease resistance, and sustainable packaging. The firm’s portfolio includes companies like Toopi Organics, which repurposes human urine as a bio-stimulant, and In Ovo, which develops sex determination technologies to reduce the culling of male chicks in the poultry industry. Clay Capital’s approach emphasizes connecting the Asian and European markets, leveraging its expertise and network to help startups expand globally. This cross-continental strategy reflects the firm’s vision of creating a healthier and more sustainable food system while fostering innovation in agrifood tech.

Clean Growth Fund (CGF) is a pioneering £101 million venture capital fund launched in 2020, dedicated to supporting early-stage clean technology companies in the UK. Backed by cornerstone investors such as CCLA and the UK government, CGF focuses on startups that are developing innovative solutions to reduce carbon emissions across critical sectors like power, energy, transport, buildings, and agriculture. The fund’s primary mission is to drive superior financial returns while accelerating the transition to a low-carbon economy, directly contributing to the UK’s Net Zero targets by 2050. CGF typically makes initial investments ranging from £500k to £3 million, primarily during Seed and Series A rounds, and plays an active role in scaling these companies. The fund’s portfolio reflects its commitment to high-impact climate tech, featuring companies like Sunswap, which has developed a zero-emission transport refrigeration unit that can reduce emissions by up to 93%, and Holiferm, a University of Manchester spinout producing eco-friendly biosurfactants for consumer products. Under the leadership of Managing Partner Beverley Gower-Jones, who has over 30 years of experience in clean tech and energy, CGF leverages deep industry expertise to provide more than just capital. The firm actively supports its portfolio companies in achieving their business goals, thus ensuring their innovations make a significant contribution to reducing global carbon emissions. CGF’s strategy aligns with its investors' goals, particularly those managing large funds like the South Yorkshire Pensions Authority and Aviva Investors, who are committed to integrating climate solutions into their portfolios​.

Cleo Capital is a venture capital firm founded in 2018 by Sarah Kunst, based in San Francisco, California. The firm focuses on early-stage investments, primarily targeting the pre-seed and seed stages. Cleo Capital is particularly committed to backing companies in sectors such as fintech, healthtech, web3, and the creator economy, with a key focus on three main investment theses: the Future of Income, Complicated Consumer, and Decentralized Enterprise. Cleo typically invests between $100K to $1M in startups with high growth potential, particularly those building software with the potential to become multi-billion-dollar enterprises. The firm has invested in over 40 companies, including notable startups like Ellevest, Kobold Metals, Hill House Home, and FalconX. As a general partner, Sarah Kunst is recognized as one of the top innovators in venture capital and has been involved in initiatives like Bumble Fund, advising underrepresented founders. Cleo Capital also places a strong emphasis on supporting entrepreneurs with long-term guidance and creating value within its portfolio.

Cleveland Avenue, founded in 2015 and based in Chicago, Illinois, is a venture capital firm that invests in lifestyle consumer brands and technology companies. The firm is dedicated to accelerating growth for entrepreneurs by providing not only financial resources but also strategic support across various business functions. Cleveland Avenue focuses on several sectors including food and beverage, AgTech, consumer goods, and health and wellness. Their portfolio includes innovative companies like Farmer’s Fridge, a vending machine company providing fresh meals; PreciTaste, an AI-enabled foodservice management platform; and Hero, a producer of zero-carb, zero-sugar foods made from plant-based proteins. The firm's approach goes beyond passive investment. They offer a range of services such as financial expertise, organizational development, marketing, supply chain optimization, and operational guidance to help their portfolio companies succeed. Their state-of-the-art Innovation Facility in Chicago serves as a hub for R&D, consumer research, and product showcases. Key figures at Cleveland Avenue include Don Thompson, the CEO, who leverages his extensive experience in corporate leadership to guide the firm's strategic vision, and Joseph McCoy, the COO and General Counsel, who brings a wealth of experience in legal and business transactions.

Climate Capital is an early-stage venture capital firm focused on investing in climate tech startups. Founded in 2018 by Sundeep Ahuja, Climate Capital aims to address climate change through strategic investments in innovative technologies that reduce emissions and promote climate adaptation. The firm supports over 350 teams working on various solutions, including clean energy production, carbon emission reduction, and sustainable lifestyle transformations. Climate Capital operates multiple funds and syndicates, such as the Seed, Growth, Bio, and Climate Scout Fund. This platform approach allows the firm to build expertise across specific verticals and leverage efficiencies of scale. The firm provides founders access to a wide network of partners, resources, and LPs to accelerate growth. Their portfolio includes companies like Mosaic, Moxion Power, and Ampaire, showcasing their commitment to diverse climate solutions. Climate Capital is highly networked, with over 2,500 climate investors, founders, operators, and enthusiasts in their community. This extensive network helps founders find talent, customers, strategic partners, and additional investors.

Climentum Capital is a Copenhagen-based venture capital firm launched in 2022, focused on investing in early-stage European climate tech startups that are driving significant CO2 reductions. The firm is particularly known for its commitment to "hard-tech" solutions—innovations that combine hardware and deep technology to address major industrial challenges. Climentum Capital invests primarily in Seed and Series A rounds, with typical investments ranging from €1 million to €5 million. The firm's investment thesis centers on six key sectors: Next Generation Renewables, Food & Agriculture, Industry & Manufacturing, Buildings & Architecture, Transportation & Mobility, and Waste & Materials. With offices in Copenhagen, Berlin, and Stockholm, Climentum has a strong presence in the Nordics and the DACH region, areas known for their leadership in sustainability and industrial innovation. Climentum Capital operates as an Article 9 fund, which under the EU's Sustainable Finance Disclosure Regulation (SFDR) means that all of its investments must have a measurable positive impact on the environment. The firm uses a dual carry structure, linking financial returns with CO2 emissions reduction goals to ensure that both economic and environmental objectives are met. In 2024, Climentum announced plans to launch a second fund, targeting €100 million to continue its mission of supporting high-impact climate tech startups across Europe. The firm has already made significant investments in companies like Qvantum and Novatron Fusion, which are developing next-generation heat pumps and fusion reactors, respectively​.

Clocktower Ventures, the venture capital arm of Clocktower Group, is based in Santa Monica, California. Since its launch in 2015, the firm has specialized in early and growth-stage investments in the fintech sector. Recently, it has expanded its focus to include climate tech startups. Clocktower Ventures' portfolio includes notable investments such as Habi, a platform for buying and selling homes in Latin America; Jeeves, a financial technology company offering corporate cards and cross-border payment solutions; and Melio Payments, which provides accounts payable solutions for small businesses. Additionally, they have invested in Helcim, a payment processing company, and Flychain, a financial operating system for healthcare providers. The firm has also seen successful exits with companies like Moneylion, which went public on the New York Stock Exchange in 2020. Clocktower Ventures emphasizes a global investment strategy, supporting innovative fintech solutions across North America and beyond. Clocktower Ventures operates under the larger umbrella of Clocktower Group, which manages investments across public and private markets with a particular emphasis on macroeconomic strategies and Chinese equities. This broader perspective allows Clocktower Ventures to leverage extensive resources and networks to support its portfolio companies effectively.

Coatue Management is a top-tier venture capital firm renowned for its investments in transformative technology companies. With notable investments in industry giants like ByteDance, Niantic, Airtable, and DoorDash, Coatue's portfolio is diverse and impressive. They focus primarily on sectors such as fintech, enterprise software, healthcare, and AI, investing globally with a strong presence in the U.S., Europe, and Asia. Coatue operates across multiple investment stages, from early-stage venture capital to growth equity and public markets. Their strategy involves deploying significant capital swiftly to capture emerging opportunities, with investments ranging from $10 million to over $100 million. They are known for their agility and ability to provide strategic support and resources to their portfolio companies. Led by founder Philippe Laffont and his brother Thomas Laffont, the team includes heavy-hitters like Dan Rose, a former VP at Facebook, and enterprise investment experts Jade Lai and Nina Gerson. They have offices in New York, Menlo Park, Los Angeles, London, and Hong Kong, reflecting their global reach. Coatue prefers startups to approach them through their network, valuing introductions that demonstrate a strong product-market fit and the potential for significant impact. The firm is highly active, often leading funding rounds and providing ongoing support to help their companies scale​.

Cocoon Capital, founded in 2016 by William Klippgen and Michael Blakey, is a venture capital firm based in Singapore. The firm focuses on seed and early-stage investments in enterprise and deep-tech startups across Southeast Asia. Cocoon Capital has a strong track record of helping startups achieve significant growth, maintaining close relationships with Series A and B funds in the region to facilitate future funding rounds​. Their portfolio includes innovative companies such as See-Mode Technologies, BuyMed, SensorFlow, and Lendela. These startups span various industries including medtech, logistics, financial software, and sustainability. Cocoon Capital's approach involves providing substantial support to founders, acting as trusted advisors and helping them navigate early-stage challenges to achieve product-market fit and scale their businesses. Cocoon Capital has made 55 investments and has had successful exits with companies like JazzyPay and FoodRazor. They focus on investing in a limited number of startups each year, allowing them to dedicate ample time and resources to each portfolio company. This hands-on model has led to a high success rate, with over 70% of their portfolio companies progressing to Series A funding.

CofounderZone is a Warsaw-based early-stage venture capital fund focusing on tech startups across Central and Eastern Europe. Its portfolio includes companies in AI, IoT, software, and automation, with a preference for B2B and B2G models. Notable investments include EcoBean, Foodsi, and Aleet. CofounderZone typically targets pre-seed and seed-stage startups, providing both capital and strategic support to propel growth. The firm is particularly active in sectors like clean tech, digital health, and fintech. CofounderZone operates with a unique model that combines angel investors and established entrepreneurs. This network offers startups deep expertise in business strategy and execution. The fund’s investment strategy emphasizes minority stakes, and it has been involved in some key rounds, including Aleet's $1.25M pre-Series A. Founders Tomasz Goliński, Ph.D., and Michał Sioda, CFA, lead the fund’s operations with extensive backgrounds in finance, corporate restructuring, and technology ventures. Their focus is on hands-on partnerships, with a strong interest in innovation-driven solutions. For startups looking to connect, CofounderZone values personalized approaches that highlight the startup’s potential for scalability and technological innovation. They are a dynamic presence in the region, steadily building a diverse investment portfolio.

Collab Capital is an Atlanta-based venture firm founded in 2020 with a mission to empower Black entrepreneurs by bridging the venture capital funding gap. Co-founded by Jewel Burks Solomon, Barry Givens, and Justin Dawkins, the firm focuses on investing in Black-owned startups, providing both capital and strategic guidance to help them grow sustainably. Their unique investment approach combines profit-sharing and equity, offering an alternative to traditional VC models, which helps founders retain more control of their businesses. With an inaugural $50 million fund, Collab Capital aims to support around 50 companies over the next few years, targeting industries like fintech, healthcare, and media. Some of their notable portfolio companies include Goodr, a sustainable food waste management platform, Hairbrella, an innovative weather-resistant headwear brand, and Jax Rideshare, which provides car rentals for gig economy workers. Their investments typically range from $500,000 to $2 million, prioritizing startups in underserved regions such as Atlanta, DC, Baltimore, and Detroit. Collab Capital’s broader goal is to foster generational wealth and economic equality by backing Black innovation and ensuring founders have the resources to scale their businesses without sacrificing ownership.

Collaborative Fund, founded in 2010 by Craig Shapiro, is a venture capital firm focused on supporting entrepreneurs and ideas that push the world forward. The firm primarily invests in early-stage companies across various sectors, including next-gen consumer products, climate solutions, industrial transformation, food innovation, and precision health. Some of their notable investments include Beyond Meat, Lyft, Impossible Foods, and Sweetgreen. The firm recently raised $200 million for two new funds: Collaborative V and Collaborative Growth. Collaborative V focuses on early-stage investments, while Collaborative Growth targets more established startups looking to scale​. Collaborative Fund's investment philosophy emphasizes sustainability, social impact, and innovative solutions that address global challenges.

Colle Capital is a global, early-stage venture fund known for its opportunistic approach. Led by founder Victoria Grace, Colle focuses on sectors such as logistics, fintech, healthcare, and advanced technology, often backing companies with strong data-driven models. Key investments include notable names like Maven Clinic, Hyliion, LiquidPiston, and MarketMuse, highlighting its diverse portfolio from digital health to AI. Based in New York, the fund does not limit itself geographically, investing across the U.S., Europe, and emerging markets. Colle Capital primarily targets seed to Series A stages, with a flexible strategy that includes both leading and co-investing in rounds. They’re known for writing checks ranging from $1M to $5M depending on the company’s potential and sector. Victoria Grace, with her background in private equity and investment banking, emphasizes supporting innovative startups with scalable impact. Colle looks for strong founders and products with a clear path to commercialization. Startups seeking to pitch should focus on data integrity, market scalability, and strategic vision, as these are critical criteria for the fund. Colle remains active in sectors with strong network effects and emerging technologies.

Collide Capital is a $66M venture fund focused on empowering diverse founders tackling global challenges. Led by Aaron Samuels and Brian Hollins, who co-founded AfroTech and BLCK VC, Collide Capital invests primarily in early-stage companies across enterprise SaaS, supply chain infrastructure, and consumer technology, with a particular emphasis on startups led by Black, Latinx, and female founders. The firm has built a notable portfolio that includes companies like Rheaply, Golde, Sidechat, and Slang.ai. With backing from major institutions like Amazon, Alphabet, and Twitter, Collide Capital is dedicated to leveling the playing field by directing resources to underrepresented entrepreneurs. They invest from pre-seed to Series A, typically leading rounds, and offering not just capital but hands-on support through a strong network of industry connections. The average check size varies but tends to be smaller early on, allowing Collide to guide startups to later stages. Based in New York, the Collide team blends deep operating and investing experience. Their mission is not only to fund the next generation of diverse founders but also to transform the venture capital landscape by making diversity and inclusion a cornerstone of innovation. Startups are encouraged to approach the firm via their website’s pitch portal, emphasizing alignment with Collide’s vision of impactful, intersectional innovation.

Colopl Next is a venture capital arm of Colopl Inc., a prominent Japanese gaming company, founded in 2015. Colopl Next focuses on investing in startups and publicly listed companies, with a strong emphasis on emerging technologies, B2C services, and the entertainment sector. The firm leverages its extensive knowledge in these areas to support young entrepreneurs and innovative companies globally. The fund's industry focus includes virtual reality (VR), augmented reality (AR), artificial intelligence (AI), blockchain, and other cutting-edge technologies. Notable investments include companies like Flitto and Kaizen Platform, which have successfully gone public. Colopl Next also has a robust presence in sectors like lifestyle services, health, and media content, supporting ventures that align with the theme of "Entertainment in Real Life". Geographically, Colopl Next primarily operates from Tokyo, Japan, but it also invests in international startups, including those in Korea and Southeast Asia. Their investment strategy includes a range of funds, such as the Next Unicorn Fund and several others dedicated to different stages and focuses, from seed investments to more mature stages. Colopl Next is known for its hands-on support approach, providing extensive resources through a network of over 200 portfolio companies, numerous advisors, and experts. This support is augmented by the diverse backgrounds of its team members, including former investment managers and successful entrepreneurs. The leadership team at Colopl Next includes key figures like Naruatsu Baba and Sehong Jang, who bring substantial experience and strategic vision to the firm. Startups seeking investment from Colopl Next are encouraged to showcase innovative technologies and robust growth potential​.

Comcast Ventures, established in 1999 and headquartered in New York, is the corporate venture capital arm of Comcast Corporation. The firm focuses on early to growth-stage investments across various sectors, including digital health, energy, fintech, future of work, and proptech. Leveraging the resources and network of Comcast NBCUniversal, Comcast Ventures aims to help its portfolio companies accelerate growth and achieve meaningful impact. Some of Comcast Ventures' notable investments include Slack, Nextdoor, Instacart, and DocuSign. These investments highlight the firm's focus on companies that drive innovation and shape the future of their respective industries. Recently, Comcast Ventures has made investments in companies like SafeBase, Hume, and HealthSnap, showcasing its commitment to supporting technology-driven solutions in healthcare and AI. The firm is led by a team of experienced partners, including Managing Partner Allison Goldberg, who plays a key role in guiding their investment strategy. Comcast Ventures' approach combines the agility of a venture fund with the strategic insights of a corporate investor, providing a comprehensive support system for startups.

Commonweal Ventures is an early-stage venture capital firm focusing on companies at the intersection of technology and public policy. The firm targets sectors such as clean energy, healthcare, financial services, transportation, and infrastructure, aiming to support startups positioned to capitalize on shifts in government regulations and public investments. Their typical investment ranges from $250K to $2M, participating in pre-seed through Series A rounds, often leading or co-leading. Founded by Nate Loewentheil, a former Obama White House official with extensive experience in infrastructure and technology, Commonweal backs startups with the potential to drive large-scale societal improvements. Notable portfolio companies include firms advancing sustainability and urban revitalization efforts​. The firm is deeply involved in helping companies navigate the evolving policy landscape to unlock growth opportunities. Their team consists of key figures from both the public and private sectors, including General Partner Ron Bloom, a former senior advisor in the U.S. government. This diverse leadership enables Commonweal to provide not only capital but also strategic guidance in areas heavily influenced by regulation.

Compound is a thesis-driven, research-centric investment firm that focuses on early-stage investments across deeply technical and science-driven areas. The firm is dedicated to accelerating the futures envisioned by its founders, helping them solve complex technical problems, communicate breakthroughs, and scale commercialization efforts. Founded by Michael Dempsey, Compound has a diverse team of investors, researchers, and operators with extensive domain expertise. Notable team members include General Partner David Hirsch and Venture Partners like Celeste Holz-Schietinger, who has a background in biology and was instrumental in creating plant-based meat products at Impossible Foods. Compound's portfolio is broad, encompassing sectors like AI/ML, robotics, healthcare, biology, and crypto. Notable investments include companies such as Deepgram, Hyphen, Arbitrum, and Dapper Labs. The firm emphasizes a hands-on approach and leverages its network and prior experiences to support the growth and success of its portfolio companies.

Connect Ventures, established in 2012 and based in London, is a venture capital firm that focuses on early-stage investments in Europe. The firm is particularly interested in product-led founders and companies that leverage emerging technologies to create or disrupt large markets. Connect Ventures has a diverse portfolio, including notable investments like Citymapper, an urban navigation app; Typeform, an online survey platform; and Curve, a fintech company that consolidates multiple bank cards into one. Recent investments also include Metomic, which helps businesses detect and control sensitive data in cloud applications, and Sprinque, a B2B checkout solution with embedded trade finance​. The firm typically invests in seed and Series A rounds, with initial check sizes ranging from €500,000 to €3 million. Connect Ventures aims to provide not just capital but also strategic guidance and support, helping startups scale and succeed in competitive markets. They are known for their hands-on approach and commitment to partnering with founders through every stage of growth.

Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm, dedicated to supporting the state's innovative and high-growth companies. Founded in 1989, CI invests across various industries, including biotech, IT, cleantech, and advanced manufacturing. They manage several funds, including the $50 million Future Fund, which targets early-stage, tech-enabled startups with diverse teams, emphasizing underrepresented founders. Investment sizes range from $250,000 to $1.5 million. Notable investments from CI’s diverse portfolio include companies like Athletic Brewing, Budderfly, and Veradermics. The firm’s commitment to diversity is further highlighted by the ClimateTech Fund, a $100 million initiative to support climate and adaptation technology ventures aimed at decarbonization and job creation in Connecticut​. Leading the team is CEO Matt McCooe, who brings over 25 years of venture capital experience. Key team members also include Alison Malloy, Managing Director of Investments, who co-manages the Future Fund, and Konstantine Drakonakis, Managing Director for the ClimateTech Fund. Connecticut Innovations prioritizes companies that are willing to maintain a presence in Connecticut, leveraging co-investment opportunities to maximize growth potential and support from a network of experienced partners and advisors. Their holistic approach involves strategic guidance, financial backing, and extensive networking opportunities to ensure portfolio companies thrive

Conscience VC is an early-stage venture capital firm that focuses on funding innovative startups aiming to make a positive impact on the world. Founded in 2020 by Ariana Thacker, the firm is headquartered in Austin, Texas. Conscience VC invests primarily in the intersection of consumer and science, with a particular emphasis on sectors such as biotechnology, digital health, clean tech, and other socially responsible industries. The firm is notable for its commitment to diversity and inclusion, with over 50% of its portfolio companies led by female and diverse founders. Ariana Thacker, the driving force behind Conscience VC, is a passionate advocate for underrepresented groups in the venture capital space, leveraging her technical background in chemical engineering to support groundbreaking companies. Conscience VC has made 14 investments to date, including companies like Aqua Cultured Foods and Somite Therapeutics, and continues to prioritize Environmental, Social, and Governance (ESG) principles in its investment strategy.

Conscious Venture Lab (CVL) is a Baltimore-based accelerator focused on supporting early-stage, purpose-driven startups that are committed to using innovation to tackle societal challenges. Launched in 2013, CVL operates a four-month immersive program designed to help founders build businesses that balance profit with a social mission. CVL specifically seeks out underrepresented and diverse entrepreneurs who are passionate about creating equitable solutions, with a focus on sectors like big data, IoT, cleantech, and cybersecurity. With a curriculum centered around stakeholder capitalism, CVL emphasizes the importance of fostering businesses that deliver value not only to shareholders but also to communities and the environment. Founders gain access to mentorship, strategic guidance, and a broad network of investors and industry leaders. The lab's portfolio includes companies like EcoMap Technologies, which focuses on democratizing data access, and other tech-driven ventures that address food security, climate resilience, and urban innovation. CVL, led by founder Jeff Cherry, has a hands-on approach to helping startups scale, providing a support system that ranges from early seed funding to Series A investments. Startups in the program benefit from connections to thought leaders and strategic partners, including both financial and governmental institutions​.

Continental Grain Company, also known as Conti, is a privately-owned global investor with a rich history spanning over 200 years in the food and agribusiness sectors. Founded in 1813, the company operates across North America, Latin America, Asia, and Europe, making investments that cover the entire food supply chain, from production to processing and distribution. Conti's investment strategy focuses on leveraging its deep industry expertise, flexible capital, and extensive partnership network to build businesses that create long-term value. This includes backing early-stage growth companies that use cutting-edge technology to innovate within the agrifood space. Notable investments in their portfolio include Pivot Bio, Brightseed, and Bushel, which are leading advancements in ag biotech, digital infrastructure, and alternative proteins. In recent years, Continental Grain has expanded its footprint through significant acquisitions and partnerships. For example, the company formed a joint venture with Cargill to acquire Sanderson Farms, creating Wayne-Sanderson Farms, a major U.S. poultry business. This move underscores Conti's commitment to scaling its operations and maintaining a strong presence in the food production sector​.

Contrary, founded in 2016 and headquartered in San Francisco, focuses on identifying and investing in top entrepreneurial talent from the seed stage through to scaling. The firm has a portfolio that spans various industries, including technology, healthcare, and financial services. Notable investments include Zepto, an on-demand grocery delivery service in India, and Ramp, a finance automation platform designed to streamline business expenses. Other significant investments are in companies like Orchard Robotics, which focuses on precision agriculture, and Memora Health, an operating system for care delivery. Contrary's investment strategy revolves around a talent-driven approach, supporting exceptional entrepreneurs with not just capital, but also strategic and operational guidance. The firm has made 87 investments and has been involved in significant exits like Rubrik and Aryeo. The leadership team, including founder Eric Tarczynski and partners like Jason Chen and Will Robbins, brings a wealth of experience in venture capital and startup growth. Contrary emphasizes building a strong community of founders and leveraging a robust network to support portfolio companies.

Coronis Medical Ventures is a venture capital firm based in Milpitas, California, focusing on early-stage investments in the medical device sector. Established in 2006, it operates as both a seed fund and a business accelerator, supporting startups in fields such as cardiovascular, neurovascular, and minimally invasive therapeutic devices. Coronis is known for providing capital, prototyping support, and hands-on development to help medical companies bring their innovations to market. With notable investments in companies like Varix Medical and VasoNova, Coronis typically leads at the seed stage, helping startups achieve proof of concept before seeking larger follow-on funding for commercialization. The firm's leadership includes veteran medical device entrepreneurs, including Mark Klopp and Roger Stern, who bring extensive industry experience​. Coronis has made a significant impact by combining venture funding with practical guidance and strategic leadership, positioning itself as a key player in medical technology innovation​.

Correlation Ventures, founded in 2006 and based in San Francisco, leverages predictive analytics to make investment decisions, positioning itself as a unique player in the venture capital landscape. With over 519 investments, the firm has backed notable companies such as IonQ, MosaicML, Imperfect Foods, and Personal Capital. Their innovative approach allows them to make rapid investment decisions, typically within two weeks, without traditional due diligence, making them a preferred co-investor for many lead venture capitalists​​. Correlation Ventures typically invests between $1 million and $4 million, focusing on diverse sectors including AI, fintech, healthcare, and consumer products. Their portfolio is characterized by a high level of diversification, including early investments in companies that have achieved significant exits such as Synthorx, which was acquired by Sanofi for $2.5 billion, and Personal Capital, acquired by Empower for $875 million​​. The firm was co-founded by David Coats and Trevor Kienzle, who continue to lead the team alongside key figures like Wesley Barrow and Grace Chui-Miller. With offices in San Francisco, San Diego, and New York City, Correlation Ventures continues to expand its influence by applying data-driven insights to support its investment strategy and portfolio growth​.

Cosmic Venture Partners, founded in 2021 and based in New York, is an early-stage venture capital firm. The firm focuses on investing in next-generation startups, particularly those operating in the tech, Web3, and consumer packaged goods (CPG) sectors. Cosmic Venture Partners aims to support innovative platforms, products, and services that have the potential to transform their respective industries. The firm was co-founded by Alexandra Tynion, Brian McNamara, and Matthew Rutler. Alexandra Tynion, who has experience with SeedInvest and Circle Financial, is based in New York City. Brian McNamara, with an MBA from Columbia Business School and a background at Jefferies, operates out of Austin, Texas. Matthew Rutler, an angel investor in over 100 startups and an EVP at MasterClass, is based in Los Angeles. Cosmic Venture Partners has made several notable investments, including GarageXYZ in the automotive sector and Goodles in food products. The firm has also achieved successful exits, such as the buyout of Nue Life and the acquisition of Kangaroo​. The firm's ethos centers on partnering with visionary founders who are not only imagining the future but actively building it. Cosmic Venture Partners provides both capital and strategic support, leveraging their extensive network and industry expertise to help startups scale and succeed.

Cota Capital, founded in 2015 and based in San Francisco, is a multi-stage investment firm focusing on enterprise technology. The firm aims to support companies through both private and public investments, leveraging a strategic and operational approach to drive growth. Cota Capital invests in sectors such as AI, cloud computing, fintech, and cybersecurity, with notable portfolio companies including OpenGov and Mission Bio. Led by founder Bobby Yazdani, Cota Capital emphasizes a partnership model, working closely with portfolio companies to build long-term value. Their investment range typically covers early to growth stages, providing substantial support to innovative ventures​.

Cottonwood Technology Fund is a venture capital firm specializing in seed and early-stage investments in technology-driven businesses. With offices in Santa Fe, New Mexico, and Enschede, the Netherlands, the fund focuses on sectors such as chemistry and material sciences, photonics, robotics, medical technology, and clean energy. Their investment strategy targets hard science and deep tech startups, providing crucial support for commercialization and global scaling. Notable investments include companies like Skorpios Technologies, BayoTech, Respira Therapeutics, Infinitum Electric, and Exagen. Cottonwood is known for its hands-on approach, offering more than just financial backing by actively helping with strategy alignment, market entry, and connecting portfolio companies with potential customers and strategic partners. The firm’s team, led by Managing Director Dave Blivin and General Partner Alain le Loux, brings diverse expertise and a strong entrepreneurial mindset, making Cottonwood a valuable partner for startups in their portfolio.

Coughdrop Capital is an early-stage venture capital firm founded by brothers Stu and Austin Smith in 2015. Based in Bend, Oregon, with a presence in San Francisco and Los Angeles, the firm typically invests $25-50K in pre-seed and seed-stage startups across various sectors. Their investment philosophy centers on backing smart, ambitious founders regardless of the industry​. The firm has a diverse portfolio that includes notable investments in companies such as Superhuman, Lattice, Mercury, Ware, Dreamship, Ever Loved, Housable, Fast, and Catch. Coughdrop Capital is known for its founder-friendly approach, often providing strategic guidance, valuable introductions, and operational support to its portfolio companies​. Stu Smith brings extensive experience from his roles at WarnerMedia and Teespring, focusing on driving innovation in the entertainment and media sectors. Austin Petersmith, on the other hand, is the founder and CEO of Capiche, a platform for honest conversations about SaaS, and has a background in growth and marketing roles at early-stage startups​. Coughdrop Capital's investment strategy emphasizes quick decision-making and maintaining a supportive relationship with founders. They have been praised for their helpfulness, integrity, and ability to stay out of the way when not needed, while being available to offer support and resources when required.

Courtside Ventures is a leading early-stage venture capital firm specializing in sports, lifestyle, and gaming investments. Founded by Vasu Kulkarni, the firm is headquartered in New York City. Courtside has a strong portfolio, including notable companies like The Athletic, StockX, and 100 Thieves. Their focus is on businesses at the intersection of sports, media, and technology, reflecting a keen interest in the content creation, distribution, and monetization spaces. With three funds totaling over $200 million in assets under management, Courtside Ventures has made over 80 active investments. They typically participate in Seed and Series A rounds, often leading the funding efforts. The firm’s geographic focus spans both the U.S. and international markets, with about 20% of their investments located outside the U.S. Courtside Ventures employs a strategic approach, prioritizing startups that can demonstrate significant potential in their niche markets. They look for passionate entrepreneurs and innovative business models that can drive growth in sports tech, wellness, and gaming. Noteworthy team members include Vasu Kulkarni, Deepen Parikh, and Kai Bond, each bringing extensive experience and a deep network in their respective fields. For startups seeking to connect with Courtside Ventures, it's crucial to present a clear vision aligned with the firm’s core investment themes. They appreciate pitches that highlight unique value propositions and scalable business models that can thrive in the ever-evolving landscape of sports, lifestyle, and gaming.

Courtyard Ventures is an early-stage venture capital firm based in Berkeley, California, focused on investing in startups that emerge from the UC Berkeley ecosystem. Founded in 2021, the firm supports student and alumni-led ventures, leveraging its connection to UC Berkeley’s innovative network. Courtyard Ventures specializes in sectors like business software, education technology, and logistics, aiming to fuel startups with high growth potential. The fund has backed companies like Ruuf, a platform in the information services space, and EdVisorly, an education-focused startup. Courtyard typically invests at the seed stage, providing early funding and strategic support to help startups navigate the complexities of scaling their businesses. Led by partners such as Dogakan Toka and Kevin Chang, Courtyard Ventures focuses on nurturing founders through its extensive network, especially within the Haas MBA program and other Berkeley alumni connections. With an eye on building category-leading companies, Courtyard Ventures is well-positioned to drive innovation from the university's entrepreneurial ecosystem.

Co-Win Ventures, founded in 2009 and based in Beijing, China, is a prominent early-stage investment firm focusing on the Technology, Media, and Telecommunications (TMT) and healthcare sectors. Their portfolio features a variety of innovative companies, including KBP Biosciences, Celsius Therapeutics, Thrive Earlier Detection, and Fluent BioSciences. The firm supports both early-stage and growth-stage companies, providing capital and strategic guidance to help them scale successfully. Co-Win Ventures has a strong presence in both China and the USA, leveraging its extensive network to foster innovation and growth. Their investment approach combines financial backing with hands-on support, ensuring that their portfolio companies have the resources they need to thrive in competitive markets. By focusing on sectors with high growth potential, Co-Win Ventures aims to drive advancements in technology and healthcare, contributing to significant industry developments. Their commitment to supporting visionary entrepreneurs has made them a key player in the venture capital landscape.

CPT Capital, based in London, is the venture capital arm of a leading private family office. The firm specializes in investing in companies revolutionizing the food and materials technology sectors, particularly in the realm of alternative proteins. CPT Capital's mission is to drive this revolution by partnering with visionary founders and supporting them from pre-seed stages through to IPO or sale. As a long-standing investor in the alternative protein space, CPT Capital focuses on plant-based proteins, biomass fermentation, recombinant proteins, and cultivated meat. Their portfolio includes groundbreaking companies like Impossible Foods, Beyond Meat, and Upside Foods, all of which are at the forefront of developing sustainable and innovative food solutions. CPT Capital seeks companies with products that directly replace animal-derived products and possess a strong technological or intellectual property component. The firm is geographically diverse, with investments spanning the US, Israel, Europe, the UK, and Asia. The firm is dedicated to addressing global challenges related to food production and sustainability, aiming to replace traditional animal protein sources with more sustainable alternatives. This approach not only promises environmental benefits but also aims to improve public health and resource efficiency.

Craft Ventures is a venture capital firm that focuses on early-stage investments in B2B software, marketplaces, and transaction-based business models. Established in 2017, Craft Ventures is led by a team of seasoned entrepreneurs and investors, including Jeff Fluhr, co-founder of StubHub, and David Sacks, former COO of PayPal. Craft Ventures' strategy includes providing more than just capital. They offer strategic support to portfolio companies, helping them build robust go-to-market strategies, optimize operations, and scale effectively. Their team comprises individuals with extensive experience in marketing, growth, and operations from successful tech startups like ClickUp and Callin. With a presence in San Francisco and a commitment to working closely with founders, Craft Ventures aims to identify and support the next generation of category-defining companies.

CRCM Ventures is a venture capital firm founded in 2004, headquartered in San Francisco, with a focus on early-stage investments in both the US and Greater China. The firm targets sectors such as healthcare and wellness, fintech, blockchain technology, media, and frontier technology. CRCM Ventures has an impressive portfolio, including three unicorns: Apollo, Blockdaemon, and Iterable. Notable public companies in their portfolio include Ginkgo Bioworks, which went public on the NYSE in 2021, and Yiju Enterprise Group, listed on the Hong Kong Stock Exchange. Additionally, CRCM has seen multiple acquisitions, such as The Drone Racing League and Spin, reflecting their success in identifying and supporting high-potential startups. The firm is led by a team of experienced professionals, including Chun Ding, who is based in San Francisco. Their investment strategy emphasizes backing innovative technology-driven companies with the potential to transform industries. CRCM Ventures combines a strong presence in Silicon Valley with deep connections in China, leveraging their dual-market expertise to drive growth and innovation in their portfolio companies. This approach allows them to provide significant value to startups looking to expand and scale their operations globally.

Creadev, established in 2002 and supported by the Mulliez family, is a global evergreen investment firm dedicated to nurturing companies that have the potential to become industry leaders. With a presence in Paris, Shanghai, New York, and Nairobi, Creadev has built a diverse portfolio across healthcare, sustainable consumption, and food sectors. One of their notable investments is Twiga Foods, a prominent food distribution platform in Kenya that uses technology to streamline the supply chain between farmers and vendors, enhancing efficiency and sustainability. Another significant investment is Victory Farms, an East African aquaculture platform addressing nutritional security through sustainable fish farming solutions. Creadev has also backed Everytable, a U.S.-based food and beverage company committed to providing affordable and healthy meals to underserved communities. In the realm of plant-based foods, Creadev has invested in The Jackfruit Company, which produces meat substitutes using jackfruit, catering to the growing demand for sustainable and healthy food options. Additionally, they support Lifen, a French health tech company offering digital solutions to improve healthcare delivery and patient management. Creadev's investment approach emphasizes long-term commitment and aligns the investment horizon with the entrepreneurial vision. They often lead funding rounds and work collaboratively with other investors to support the growth and expansion of their portfolio companies. This strategy reflects their dedication to fostering sustainable and impactful businesses globally​.

Creandum is a leading European venture capital firm that specializes in early-stage investments, focusing on technology-driven companies within the consumer, software, and hardware industries. Founded in 2003, Creandum operates from its hubs in Stockholm, Berlin, London, and San Francisco, and is renowned for its thesis-driven approach to investing. The firm's notable portfolio includes high-profile companies such as Spotify, Klarna, Bolt, Depop, and Kahoot!. Creandum has also recently raised its seventh fund, a €500 million vehicle dedicated to supporting seed and early-stage startups across Europe. This fund aims to continue backing innovative companies poised to become global leaders. Creandum's investment philosophy emphasizes long-term commitment to founders, supporting them through the various stages of their growth journey. The firm prides itself on its deep industry expertise and extensive network, which it leverages to help startups scale and succeed in competitive markets. Recent investments include companies like Prewave, a supply chain disruption solution, and Plancraft, a platform digitizing work processes in the craft industry.

Creative Ventures is a venture capital firm focusing on market-driven deep technology investments. They invest in early-stage B2B companies that are commercializing novel scientific and engineering innovations. Key investment sectors include climate change adaptation and mitigation, healthcare, and addressing labor shortages in industrial and service sectors. The firm prides itself on a market-first approach, ensuring that the technologies they invest in are primed to meet existing market demand rather than speculative future needs. This strategy helps mitigate risks associated with deep tech investments​ (Creative Ventures)​​ (Creative Ventures)​. Creative Ventures has been a lead or co-lead investor in 80% of their investments from the current fund, often being the first institutional investor on a company's cap table​. Notable portfolio companies include Path Robotics, Sepion Technologies, and OncoPrecision, which focus on autonomous welding robots, advanced materials for energy storage, and oncology drug efficacy, respectively​. The team, led by General Partners Alex Luce and Kulika Weizman, brings extensive expertise in areas such as material science, synthetic biology, and biotechnology.

Creator Fund is a venture capital firm focused on backing scientific founders at the pre-seed and seed stages, primarily across the UK and Europe. Founded in 2019 by Jamie Macfarlane, the fund specializes in investing in deep technology and life sciences startups that emerge from university research. With a unique model, Creator Fund operates a network of PhD students across 25+ leading European universities, helping to identify promising ventures at the earliest stages of development. Creator Fund typically invests between £100,000 to £700,000 in early-stage startups, often backing companies where at least one founder is an academic—whether a professor, PhD, or recent graduate. They have built a diverse portfolio, including companies like Baseimmune (biotechnology) and Recycleye (AI-driven waste management). Their sector focus spans deep tech areas such as artificial intelligence, robotics, quantum computing, and biotech, aiming to support founders who are pioneering breakthroughs in their fields. Their investment strategy also emphasizes long-term involvement, often supporting founders through multiple funding rounds and connecting them with a strong network of co-investors across Europe and the U.S. The fund's leadership team, alongside Macfarlane, includes seasoned professionals who bring expertise from venture capital and deep-tech industries.

Crédit Mutuel Equity, the private equity arm of Crédit Mutuel Alliance Fédérale, focuses on supporting companies at various stages of their development, from early-stage growth to transformation and international expansion. Based in France, the firm has a diverse portfolio encompassing over 350 companies globally. Key investments include UroMems, which develops implantable mechatronics technology for medical applications; Quandela, a leader in quantum photonics; and HarfangLab, a cybersecurity company specializing in endpoint detection and response. Other notable companies in their portfolio are Latitude, a space launcher operator, and MentorShow, an EdTech SaaS platform. Crédit Mutuel Equity invests across multiple sectors, including healthcare, technology, consumer goods, energy, real estate, and logistics. They typically support companies with innovative business models and substantial growth potential, providing both financial investment and strategic guidance to help them scale and succeed.

Crescendo Venture Partners (CR-VP) is a Tel Aviv-based venture capital firm focused on investing in early-stage companies that leverage next-generation technologies such as Big Data, AI, and Machine Learning. Founded by a team of seasoned venture capitalists with over 75 years of combined experience, CR-VP seeks to partner with ambitious entrepreneurs who aim to build sustainable, profitable businesses that can become category leaders in their respective industries. The firm emphasizes supporting startups that offer simple, scalable solutions to complex problems across substantially-sized markets. CR-VP's approach involves not only providing capital but also offering strategic support to help companies navigate the journey from inception to exit. CR-VP's portfolio includes notable companies like WalkMe, which went public, and Cyota, which was acquired by RSA. The firm also collaborates with the Geneva-based Crescendo Group, providing access to untapped sources of capital and broadening the reach to European, LATAM, and Asian markets.